- $96.06m
- $78.85m
- $19.61m
- 42
- 25
- 95
- 54
Annual income statement for icad, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 29.7 | 33.6 | 19.8 | 17.3 | 19.6 |
| Cost of Revenue | |||||
| Gross Profit | 21.4 | 24.2 | 16.8 | 14.8 | 16.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 39.4 | 44.8 | 30 | 25 | 25.9 |
| Operating Profit | -9.73 | -11.1 | -10.2 | -7.69 | -6.27 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -17.6 | -11.2 | -10 | -6.99 | -5.52 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17.6 | -11.2 | -9.92 | -7.01 | -5.62 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -17.6 | -11.2 | -13.7 | -4.85 | -5.62 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -17.6 | -11.2 | -13.7 | -4.85 | -5.62 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.785 | -0.444 | -0.394 | -0.274 | -0.209 |